Kevin J Appelbaum Insider Profile
4 Followers
Kevin J Appelbaum, CEO, Director, Ten Percent Owner at Better Therapeutics, holds 2.41M shares in Better Therapeutics (Ticker: BTTX). Most recently, Kevin J Appelbaum Bought 2,500 shares of Better Therapeutics on Apr 04, 2022 for an estimated value of $4.90K.
Kevin J Appelbaum's Trading History
| BTTXBetter Therapeutics | Apr 04, 2022 | CEO, Director, Ten Percent Owner | Informative Buy | 4.90K | ― | |
BTTX Insider Shares: 2.41M (0.00%) | ||||||
You May Also Like
Kevin J Appelbaum insider profile FAQ
What is the percentage of profitable transactions made by Kevin J Appelbaum?
The percentage of profitable transactions made by Kevin J Appelbaum is 0%.
What is the average return per transaction made by Kevin J Appelbaum?
The average return per transaction made by Kevin J Appelbaum is -69.60%.
What stocks does Kevin J Appelbaum hold?
Kevin J Appelbaum holds: BTTX stocks.
What was Kevin J Appelbaum’s latest transaction?
Kevin J Appelbaum’s latest transaction was an Informative Buy of $4.90K.
What was Kevin J Appelbaum's most profitable transaction?
Kevin J Appelbaum’s most profitable transaction was an Informative Buy of BTTX stock on April 4, 2022. The return on the trade was -61.80%.
What is Kevin J Appelbaum's role in Better Therapeutics?
Kevin J Appelbaum's role in Better Therapeutics is CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
